Karen Krasney

Track

Insider profile

Currently holds a position at Capricor Therapeutics Inc

Positions

Position Company Period
Executive Vice President, General Counsel Capricor Therapeutics Inc Nov. 22, 2013 -
Karen Krasney's trades of Capricor Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-29 2026-06-25
PlS Planned sale
12,134 +3.7%
426.08
US$4,744,051 		12,134 +3.7% 426.08 US$4,744,051
2026-06-24 2026-06-24
PlS Planned sale
14,821 +3.0%
380.12
US$1,849,945 		14,821 +3.0% 380.12 US$1,849,945
2026-06-24 2026-06-22
PlS Planned sale
64,938 -41.3%
140.98
US$2,017,145 		64,938 -41.3% 140.98 US$2,017,145
2026-05-04 2026-05-01
PlS Planned sale
25,000 -45.0%
31.70
US$792,548 		25,000 -45.0% 31.70 US$792,548
2026-05-04 2026-05-01
PlS Planned sale
25,000 -45.0%
31.70
US$792,548 		25,000 -45.0% 31.70 US$792,548
2026-04-01 2026-03-31
PlS Planned sale
25,000 -45.0%
30.12
US$752,935 		25,000 -45.0% 30.12 US$752,935
2026-03-31 2026-03-31
PrS Proposed sale
75,000
27.77
US$2,082,750 		75,000 27.77 US$2,082,750